IFNG and type 2 diabetes mellitus: Moreover, B cells activate T-cell-mediated systemic inflammation and decrease anti-inflammatory cytokine IL-10 expression in obese mice and patients with type 2 diabetes, respectively10, 11, and T cells promote chronic inflammation in diabetes patients through interferon gamma (IFN-γ) and IL-17 production12.